These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11729805)

  • 21. Methadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-up.
    Rhodin A; Grönbladh L; Nilsson LH; Gordh T
    Eur J Pain; 2006 Apr; 10(3):271-8. PubMed ID: 15972261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Documented effect of methadone, but not naltrexone].
    Heilig M
    Lakartidningen; 2002 Feb; 99(6):551-2. PubMed ID: 11881232
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 26. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
    Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
    Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment.
    Winklbaur B; Jagsch R; Ebner N; Thau K; Fischer G
    Eur Addict Res; 2008; 14(2):99-105. PubMed ID: 18334820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is methadone therapy inexpensive?].
    Volfing B
    Ugeskr Laeger; 2002 Oct; 164(41):4827. PubMed ID: 12407897
    [No Abstract]   [Full Text] [Related]  

  • 29. [Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program].
    Habrat B; Chmielewska K; Baran-Furga H; Keszycka B; Taracha E
    Przegl Lek; 2002; 59(4-5):351-4. PubMed ID: 12184005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined.
    Winstock AR; Nittis M; Whitton G; Lea T
    Int J Drug Policy; 2009 Jan; 20(1):85-9. PubMed ID: 18164193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Driving capacity of patients treated with methadone and slow-release oral morphine.
    Giacomuzzi SM; Ertl M; Vigl A; Riemer Y; Günther V; Kopp M; Pilsz W; Haaser W
    Addiction; 2005 Jul; 100(7):1027. PubMed ID: 15955021
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the change of quality of life and its influential factors for drug abusers accepting methadone maintenance treatment].
    Zhang H; Li XL; Chen MS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):206-7. PubMed ID: 19565892
    [No Abstract]   [Full Text] [Related]  

  • 37. [Buprenorphine and methadone to opiate addicts--a randomized trial].
    Kristensen Ø; Espegren O; Asland R; Jakobsen E; Lie Ø; Seiler S
    Tidsskr Nor Laegeforen; 2005 Jan; 125(2):148-51. PubMed ID: 15665884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supervised methadone consumption: client issues and stigma.
    Anstice S; Strike CJ; Brands B
    Subst Use Misuse; 2009; 44(6):794-808. PubMed ID: 19444722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
    Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
    Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing to drug misusers in practice--often effective, but rarely straightforward.
    Seivewright N; Iqbal MZ
    Addict Biol; 2002 Jul; 7(3):269-77. PubMed ID: 12126485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.